WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editorials
Caixin's In-Depth Look at China's Health Insurance Dilemma and Transformation(4/23/2019 )  (Premium)
Editor´s Picks
Wary of Chinese Espionage, Houston Cancer Center Chose to Fire 3 Scientists(4/23/2019 )  (Premium)
Industry News
Inifinity Research: Key Market Entry Barriers to the Chinese Pharma Industry(4/23/2019 )  (Premium)
Boehringer Ingelheim Increases Focus on Chinese Rural Areas(4/23/2019 )  (Premium)
Lilly Announces Sale of Legacy Antibiotics Brands and Manufacturing Facility in China(4/22/2019 )  (Premium)
China to Amend Healthcare Laws Relating to Physicians(4/22/2019 )  (Premium)
General Health
China Releases Outcomes of Its First Nationwide Mental Health Survey(4/23/2019 )  (Premium)
Legal/IPR News
CNIPA Releases Draft Amendments to the Guidelines for Patent Examination(4/23/2019 )  (Premium)
China's Legislature Begins Second Review of the Proposed Vaccine Management Law(4/23/2019 )  (Premium)
Amendment of Drug Administration Law and Draft Vaccine Management Law Submitted to the NPC for Review(4/22/2019 )  (Premium)
Product/R&D News
Hua Medicine Initiates First Combination Study of Dorzagliatin with SGLT-2 in the U.S.(4/23/2019 )  (Premium)
© Wicon International GroupˇˇSupport by: www.heightow.com Home | Site map | Contact Us | Links